Core Insights - The meeting between U.S. President Trump and Novartis CEO Vas Narasimhan highlighted the company's plans to build 11 factories in the U.S. due to tariff policies [1][2] - Novartis is progressing with the construction of manufacturing and research facilities in North Carolina and California, and plans to establish a new factory in Florida to expand its radioligand therapy manufacturing network [2] Company Developments - Novartis announced plans to invest $23 billion in the U.S. to build and expand 10 facilities following threats of drug import tariffs from the Trump administration [2]